Clinical Trial Update: Long Term Follow-up Observational Study After Clinical Trials of AMG531 (Romiplostim) in Patients With Untreated Aplastic Anemia

View source ↗

Summary

A long-term follow-up observational study of Romiplostim (AMG531) in patients with untreated aplastic anemia, building on prior clinical trials.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia

Drugs mentioned

• Nplate (Romiplostim) (Romiplostim)

Snippet

Sponsor: Kyowa Kirin Co., Ltd. | Conditions: Aplastic Anemia | Status: ACTIVE_NOT_RECRUITING